Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 60 results.
User Information
Export Records
  1. 1.   CD19-positive antibody-secreting cells provide immune memory
  2. Groves, C. J.; Carrell, Jeff; Grady, R.; Rajan, B.; Morehouse, C. A.; Halpin, R.; Wang, J.; Wu, J.; Shrestha, Y.; Rayanki, R.; Kolbeck, R.; Wang, Y.; Herbst, R.
  3. Blood advances. 2018, NOV 27; 2(22): 3163-3176.
  1. 2.   Multiple-response regression analysis links magnetic resonance imaging features to de-regulated protein expression and pathway activity in lower grade glioma.
  2. Lehrer, Michael; Bhadra, Anindya; Ravikumar, Visweswaran; Chen, James Y; Wintermark, Max; Hwang, Scott N; Holder, Chad A; Huang, Erich P; Fevrier-Sullivan, Brenda; Freymann, John; Rao, Arvind
  3. Oncoscience. 2017, Jun 23; 4(5-6): 57-66.
  1. 3.   Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies
  2. Nayar, Utthara; Sadek, Jouliana; Reichel, Jonathan; Hernandez-Hopkins, Denise; Akar, Gunkut; Barelli, Peter J.; Sahai, Michelle A.; Zhou, Hufeng; Totonchy, Jennifer; Jayabalan, David; Niesvizky, Ruben; Guasparri, Ilaria; Hassane, Duane; Liu, Yifang; Sei, Shizuko; Shoemaker, Robert; Warren, J. David; Elemento, Olivier; Kaye, Kenneth M.; Cesarman, Ethel
  3. JOURNAL OF CLINICAL INVESTIGATION. 2017, Jun; 127(6): 2066-2080.
  1. 4.   Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
  2. Newman, D. J.; Cragg, G. M.
  3. Journal of Natural Products. 2012, Mar; 75(3): 311-335.
  1. 5.   Emerging Viruses in the Felidae: Shifting Paradigms
  2. O'Brien, S. J.; Troyer, J. L.; Brown, M. A.; Johnson, W. E.; Antunes, A.; Roelke, M. E.; Pecon-Slattery, J.
  3. Viruses-Basel. 2012, Feb; 4(2): 236-257.
  1. 6.   Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition
  2. Guo, W.; Wu, S. H.; Wang, L.; Wei, X. L.; Liu, X. Y.; Wang, J.; Lu, Z. M.; Hollingshead, M.; Fang, B. L.
  3. Plos One. 2011, Dec; 6(12):
  1. 7.   Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
  2. Zenatti, P. P.; Ribeiro, D.; Li, W. Q.; Zuurbier, L.; Silva, M. C.; Paganin, M.; Tritapoe, J.; Hixon, J. A.; Silveira, A. B.; Cardoso, B. A.; Sarmento, L. M.; Correia, N.; Toribio, M. L.; Kobarg, J.; Horstmann, M.; Pieters, R.; Brandalise, S. R.; Ferrando, A. A.; Meijerink, J. P.; Durum, S. K.; Yunes, J. A.; Barata, J. T.
  3. Nature Genetics. 2011, Oct; 43(10): 932-U31.
  1. 8.   Resolving the identity myth: Key markers of functional CD4(+)FoxP3(+) regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. International Immunopharmacology. 2011, Oct; 11(10): 1489-1496.
  1. 9.   Measurement of (1)H-(15)N and (1)H-(13)C residual dipolar couplings in nucleic acids from TROSY intensities
  2. Ying, J. F.; Wang, J. B.; Grishaev, A.; Yu, P.; Wang, Y. X.; Bax, A.
  3. Journal of Biomolecular Nmr. 2011, Sep; 51(1-2): 89-103.
  1. 10.   Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production
  2. Mannon, P. J.; Hornung, R. L.; Yang, Z. Q.; Yi, C. L.; Groden, C.; Friend, J.; Yao, M.; Strober, W.; Fuss, I. J.
  3. Gut. 2011, Apr; 60(4): 449-455.
  1. 11.   Localized Delivery of Interferon-beta by Lactobacillus Exacerbates Experimental Colitis
  2. McFarl, A. P.; Savan, R.; Wagage, S.; Addison, A.; Ramakrishnan, K.; Karwan, M.; Tri, D.; Young, H. A.
  3. Plos One. 2011, Feb; 6(2): 13.
  1. 12.   Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors
  2. Lee, S.; Yagita, H.; Sayers, T. J.; Celis, E.
  3. Cancer Immunology Immunotherapy. 2010, Jul; 59(7): 1073-1081.
  1. 13.   Neurodegeneration Induced by PVC-211 Murine Leukemia Virus Is Associated with Increased Levels of Vascular Endothelial Growth Factor and Macrophage Inflammatory Protein 1 alpha and Is Inhibited by Blocking Activation of Microglia
  2. Li, X. J.; Hanson, C.; Cmarik, J. L.; Ruscetti, S.
  3. Journal of Virology. 2009 83(10): 4912-4922.
  1. 14.   The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
  2. Lucas, D. M.; Edwards, R. B.; Lozanski, G.; West, D. A.; Shin, J. D.; Vargo, M. A.; Davis, M. E.; Rozewski, D. M.; Johnson, A. J.; Su, B. N.; Goettl, V. M.; Heerema, N. A.; Lin, T. S.; Lehman, A.; Zhang, X. L.; Jarjoura, D.; Newman, D. J.; Byrd, J. C.
  3. Blood. 2009 113(19): 4656-4666.
  1. 15.   Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
  2. Sissung, T. M.; Thordardottir, S.; Gardner, E. R.; Figg, W. D.
  3. Anti-cancer agents in medicinal chemistry. 2009 9(10): 1058-1069.
  1. 16.   Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
  2. Hallett, W.; Ames, E.; Motarjemi, M.; Barao, I.; Shanker, A.; Tamang, D. L.; Sayers, T. J.; Hudig, D.; Murphy, W. J.
  3. Journal of Immunology. 2008 180(1): 163-170.
  1. 17.   Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
  2. Shanker, A.; Brooks, A. D.; Tristan, C. A.; Wine, J. W.; Elliott, P. J.; Yagita, H.; Takeda, K.; Smyth, M. J.; Murphy, W. J.; Sayers, T. J.
  3. Journal of the National Cancer Institute. 2008 100(9): 649-662.
  1. 18.   One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
  2. Lee, K. M.; Lan, Q.; Kricker, A.; Purdue, M. P.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Kang, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Human Genetics. 2007, Dec; 122(5): 525-533.
  1. 19.   Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. British Journal of Cancer. 2007, Oct; 97(8): 1116-1123.
  1. 20.   Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo
  2. Gills, J.; Lo Piccolo, J.; Tsurutani, J.; Shoemaker, R. H.; Best, C. J. M.; Abu-Asab, M. S.; Borojerdi, J.; Warfel, N. A.; Gardner, E. R.; Danish, M.; Hollander, M. C.; Kawabata, S.; Tsokos, M.; Figga, W. D.; Steeg, P. S.; Dennis, P. A.
  3. Clinical Cancer Research. 2007, Sep; 13(17): 5183-5194.
  1. 21.   Interleukin 10 and TNF alpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia
  2. Iribarren, P.; Chen, K.; Gong, W.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Neurobiology of Disease. 2007, Jul; 27(1): 90-98.
  1. 22.   Thalidomide analogues as anticancer drugs
  2. Aragon-Ching, J. B.; Li, H. Q.; Gardner, E. R.; Figg, W. D.
  3. Recent Patents on Anti-Cancer Drug Discovery. 2007, Jun; 2(2): 167-174.
  1. 23.   Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells
  2. Chen, X.; Howard, O. M. Z.; Oppenheim, J. J.
  3. Journal of Immunology. 2007, May; 178(10): 6123-6129.
  1. 24.   Interferon: Cellular executioner or white knight?
  2. Maher, S. G.; Romero-Weaver, A. L.; Scarzello, A. J.; Gamero, A. M.
  3. Current Medicinal Chemistry. 2007 14(12): 1279-1289.
  1. 25.   Importance of the stress kinase p38 alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells
  2. Warfel, N. A.; Lepper, E. R.; Zhang, C. Y.; Figg, W. D.; Dennis, P. A.
  3. Clinical Cancer Research. 2006, Jun; 12(11): 3502-3509.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel